Back to Search
Start Over
ViaLase receives CE Mark for its ViaLase Laser, a femtosecond laser for glaucoma treatment
- Source :
- PharmaBiz. August 1, 2024
- Publication Year :
- 2024
-
Abstract
- ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, announced that it has received CE (Conformité Européenne) Mark approval in the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.803410091